[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345156-105":59,"doc-detail-345156-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","higher-order-synthetic-lethals-are-keys-to-minimize-cancer-treatment-effects-on-non-tumor-cells","Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells","","Cancer cells often rewire metabolism to obtain essential precursors that sustain uncontrolled tumor growth. Targeting single essential genes can fail due to resistance, limited druggability, and possible damage to non-tumor tissues. This study evaluates synthetic lethal sets using context-specific genome-scale metabolic models across 13 cancer types, introducing strictly-selective drug targets (SSDTs) and verifying their safety across corresponding non-tumor tissues.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/higher-order-synthetic-lethals-are-keys-to-minimize-cancer-treatment-effects-on-non-tumor-cells/345156/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/higher-order-synthetic-lethals-are-keys-to-minimize-cancer-treatment-effects-on-non-tumor-cells/345156.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in cancer treatment targeting?","Question",{"text":112,"@type":113},"The study addresses limitations of targeting single essential genes, including resistance, lack of targetable oncogenes, and risk of harming non-tumor cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study evaluate synthetic lethal strategies?",{"text":117,"@type":113},"It theoretically examines synthetic lethal sets across 13 cancer types using context-specific genome-scale metabolic models and examines effects on corresponding non-tumor tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the key concept introduced to reduce side effects?",{"text":121,"@type":113},"The study introduces strictly-selective drug targets (SSDTs) and verifies that identified targets show lack of harmful effects in all 13 non-tumor tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345156,1790863829,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","OPEN ACCESS  \nCitation: Dehghan Manshadi M, Setoodeh P, Ramezani A, Rajabzadeh AR, Zare H (2026) Higher order synthetic lethals are keys to minimize cancer treatment effects on nontumor cells. PLoS One 21(4): e0342199 .  \n[https://doi.org/10.1371/journal.pone.0342199](https://doi.org/10.1371/journal.pone.0342199)  \nEditor: Bashir Sajo Mienda, Federal University Dutse, NIGERIA  \nReceived: February 13, 2025  \nAccepted: January 19, 2026  \nPublished: April 15, 2026  \nCopyright: © 2026 Dehghan Manshadi et al. This is an open access article distributed under the terms of the Creative Commons Attribution  License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All data, code, and supplementary information related to this work are available at [https://github.com/](https://github.com/)[ ](https://github.com/)CSBLaboratory/CancerSSDTs.  \nFunding: This work is supported by  \nNIH–NIA (grant numbers: R01AG057896,  \nRESEARCH ARTICLE  \nHigher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells  \nMehdi Dehghan Manshadi1,2,3, Payam Setoodeh3,4*, Amin Ramezani5,6, Amin Reza Rajabzadeh4,7☯*, Habil Zare8☯*  \n1 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, 2 Algorithmic Dynamics Lab, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden, 3 Department of Chemical Engineering, School of Chemical, Petroleum and Gas Engineering, Shiraz University, Shiraz, Iran, 4 W Booth School of Engineering Practice and Technology, McMaster University, Hamilton, Ontario, Canada, 5 Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, 6 Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran, 7 School of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada, 8 Haba Businesses, San Antonio, Texas, United States of America,  \n☯ These authors contributed equally as the co-senior authors.  \n* [payamst@shirazu.ac.ir](payamst@shirazu.ac.ir), [setoodep@mcmaster.ca](setoodep@mcmaster.ca) (PS); [rajaba@mcmaster.ca](rajaba@mcmaster.ca) (ARR);  \n[zare@uthscsa.edu](zare@uthscsa.edu) (HZ)  \nAbstract  \nMetabolic rewiring in cancer cells facilitates the supply of essential precursors for uncontrolled tumor growth. Exploring these cancer-specific metabolic alterations offers potential selective therapeutic strategies. However, targeting a single essential gene in cancer treatment often faces challenges, including resistance, lack of targetable oncogenes, and potential harm to non-tumor cells. Targeting multiple genes has been proposed as a solution to overcome these issues, e.g. , a synthetic lethal (SL) set, defined as a minimal combination of non-lethal genetic perturbations that lead to cell death. This study theoretically examined the potential of SL sets to identify selective drug targets across 13 cancer types and the corresponding non-tumor tissues, utilizing context-specific genome-scale metabolic models. To ensure the minimization of therapeutic side effects, this work introduced the concept of strictly-selective drug targets (SSDTs) and the lack of harmful effects of the identified targets in all 13 different non-tumor tissues was meticulously verified. Accordingly, for 13 types of cancers, over 500 SSDTs were identified, predominantly including higher-order SL sets with more than two targets in each set. Interestingly, for specific cancers where single essential or SL genes could not provide viable therapeutic solutions, SSDTs were provided by higher-order SL sets. Thus, for the first time, this study demonstrates that leveraging higher-order SL sets may offer promising strictly selective therapeutic solutions. Furthermore, nine quadruple SSDTs were identified, which commonly target five different cancers w","cbCaieInfcBjUgNl","https://ap.wps.com/l/cbCaieInfcBjUgNl","pdf",4475140,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the study address in cancer treatment targeting?\",\"answer\":\"The study addresses limitations of targeting single essential genes, including resistance, lack of targetable oncogenes, and risk of harming non-tumor cells.\"},{\"question\":\"How does the study evaluate synthetic lethal strategies?\",\"answer\":\"It theoretically examines synthetic lethal sets across 13 cancer types using context-specific genome-scale metabolic models and examines effects on corresponding non-tumor tissues.\"},{\"question\":\"What is the key concept introduced to reduce side effects?\",\"answer\":\"The study introduces strictly-selective drug targets (SSDTs) and verifies that identified targets show lack of harmful effects in all 13 non-tumor tissues.\"}]","Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells | PDF",1790056675,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/332c7edc0008e9c1f9c3fd12bf27d389.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c1b0b5f7bb5e51924ec4942184a2c95.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e586215d50c5cb6eaee2cc71e1fc2f9f.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ead183ce7f74cdeadb8da9826257d41.webp",980,1268]